as on November 1, 2025 at 1:29 am IST
Day's Low
Day's High
1.20%
Downside
2.40%
Upside
52 Week's Low
52 Week's High
60.46%
Downside
45.51%
Upside
Check Coherus Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$197.6M
EPS (TTM)
-1.31
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.76%
PE Ratio (TTM)
3.21
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
-83.8M
Revenue (TTM)
272.2M
Profit Margin
66.03%
Return On Equity TTM
33.11%
Track how Coherus Biosciences Inc P/E has moved over time to understand its valuation trends.
Coherus Biosciences Inc in the last 5 years
Lowest (-25.72x)
September 30, 2021
Industry (-0.81x)
November 1, 2025
Today (3.21x)
November 1, 2025
Highest (141.62x)
June 30, 2021
Today’s Price to Earnings Ratio: 3.21x
Compare market cap, revenue, PE, and other key metrics of Coherus Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $197.6M | -89.92% | 3.21 | 66.03% | |
| BUY | $40.4B | 475.59% | -16.34 | -264.83% | |
| BUY | $59.4B | 270.85% | -505.15 | -12.96% | |
| BUY | $107.7B | 104.25% | 29.84 | 31.86% | |
| BUY | $68.7B | 19.91% | 15.67 | 32.13% |
The Coherus Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Coherus Biosciences Inc investment value today
Current value as on today
₹2,37,586
Returns
₹1,37,586
(+137.59%)
Returns from Coherus Biosciences Inc Stock
₹1,31,944 (+131.94%)
Dollar Returns*
₹5,642 (+5.64%)
Based on 16 analysts
81.25%
Buy
18.75%
Hold
0.00%
Sell
Based on 16 analysts, 81.25% of analysts recommend a 'BUY' rating for Coherus Biosciences Inc. Average target price of $5.67
Get share price movements and forecasts by analysts on Coherus Biosciences Inc.
What analysts predicted
70.55%UPSIDE
Target Price
$5.67
Current Price
$1.67
Analyzed by
16 Analysts
Target
$5.67
Coherus Biosciences Inc target price $5.67, a slight upside of 70.55% compared to current price of $1.67. According to 16 analysts rating.
Search interest for Coherus Biosciences Inc Stock has increased by 56% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:56% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 7.59M → 10.25M (in $), with an average increase of 25.9% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -56.56M → 297.76M (in $), with an average increase of 119.0% per quarter
Price Rise
![]()
In the last 3 months, CHRS stock has moved up by 93.7%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 184.3% return, outperforming this stock by 49.2%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1009.8% return, outperforming this stock by 1090.4%
| Organisation | Coherus Biosciences Inc |
| Headquarters | 333 Twin Dolphin Drive, Redwood City, CA, United States, 94065 |
| Industry | Health Technology |
| CEO | Mr. Dennis M. Lanfear |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Theresa M. Lavallee Ph.D. | Chief Development Officer & Chairman of Scientific Advisory Board |
Mr. Scott Saywell | Executive Vice President of Corporate Development |
Ms. Rebecca Sunshine | Chief Human Resources Officer |
Mr. Michael Chen | Senior Vice President of Commercial Analytics & Trade |
Mr. Andy Rittenberg | Executive Vice President of General Counsel |
Dr. Rosh Dias M.D., MRCP | Chief Medical Officer |
Mr. Dennis M. Lanfear | Chairman, President & CEO |
Mr. Bryan J. McMichael | Chief Financial Officer |
Ms. Jodi Sievers | Vice President of Investor Relations & Corporate Communications |
Coherus Biosciences Inc share price today is $1.67 as on at the close of the market. Coherus Biosciences Inc share today touched a day high of $1.71 and a low of $1.65.
Coherus Biosciences Inc share touched a 52 week high of $2.43 on and a 52 week low of $0.66 on . Coherus Biosciences Inc stock price today i.e. is closed at $1.67,which is 31.28% down from its 52 week high and 152.92% up from its 52 week low.
Coherus Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Coherus Biosciences Inc (CHRS) shares with as little as ₹88.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.65 in Coherus Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Coherus Biosciences Inc share’s latest price of $1.67 as on November 1, 2025 at 1:29 am IST, you will get 5.9880 shares of Coherus Biosciences Inc. Learn more about
fractional shares .
Coherus Biosciences Inc stock has given -89.92% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?